Back to funds

Deep Track Capital, LP

Updated 6 days ago

Managed by Deep Track Capital, Lp • Latest filing Q3 2026

Portfolio value
$6.1B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
96.8%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$5.6B
Q1 2026$6.1B
Q2 2026$6.9B
Q3 2026$6.1B

Top holdings

74 positions as of Q3 2026

View filing
G

GUARDANT HEALTH INC

Value
$500.4M
Shares
2.81M
% Port
8.15%
B

BIOMARIN PHARMACEUTICAL INC

Value
$382.5M
Shares
6.37M
% Port
6.23%
I

IMMUNOVANT INC

Value
$309.5M
Shares
9.16M
% Port
5.04%
T

TARSUS PHARMACEUTICALS INC

Value
$299.3M
Shares
3.81M
% Port
4.87%
M

VERADERMICS INC

Value
$230.3M
Shares
1.90M
% Port
3.75%
V

VERA THERAPEUTICS INC

Value
$226M
Shares
7.00M
% Port
3.68%
P

VAXCYTE INC

Value
$199.9M
Shares
3.51M
% Port
3.26%
A

ALKERMES PLC

Value
$182.3M
Shares
4.50M
% Port
2.97%
O

OCULAR THERAPEUTIX INC

Value
$168.3M
Shares
21.94M
% Port
2.74%
U

UNITED THERAPEUTICS CORP DEL

Value
$162.6M
Shares
300.0K
% Port
2.65%
G

STRUCTURE THERAPEUTICS INC

Value
$156.3M
Shares
5.00M
% Port
2.55%
G

GRAIL INC

Value
$154.7M
Shares
1.10M
% Port
2.52%
I

INSMED INC

Value
$154.1M
Shares
1.35M
% Port
2.51%
C

COMPASS PATHWAYS PLC

Value
$151.3M
Shares
12.16M
% Port
2.46%
G

GENMAB A/S

Value
$149.2M
Shares
4.18M
% Port
2.43%
A

AXSOME THERAPEUTICS INC.

Value
$147.5M
Shares
800.0K
% Port
2.40%
N

NURIX THERAPEUTICS INC

Value
$142.3M
Shares
6.00M
% Port
2.32%
L

LB PHARMACEUTICALS INC

Value
$128.7M
Shares
3.35M
% Port
2.10%
T

TANGO THERAPEUTICS INC

Value
$112.3M
Shares
4.50M
% Port
1.83%
M

MAZE THERAPEUTICS INC

Value
$111M
Shares
4.08M
% Port
1.81%

Explore